(c) 2024 PillSync.com

ibuprofen tablet

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of Ibuprofen Tablets and other treatment options before deciding to use Ibuprofen Tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [see WARNINGS ]. Ibuprofen Tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. Ibuprofen Tablets are indicated for relief of mild to moderate pain. Ibuprofen Tablets are also indicated for the treatment of primary dysmenorrhea. Controlled clinical trials to establish the safety and effectiveness of ibuprofen tablets in children have not been conducted.

amneal pharmaceuticals of new york llc


4 years ago ROUND WHITE IP 131 400 ibuprofen tablet

ROUND WHITE IP 131 400

4 years ago ROUND WHITE IP 131 400 ibuprofen tablet

IP 131 400 ROUND WHITE

HOW SUPPLIED

IBUPROFEN Tablets, USP are available in the following strength, color and sizes: 400 mg (round, convex, white, film-coated tablets, debossed with "IP 131" on one side, on other side debossed with "400"). They are available as follows: Bottles of 100: NDC 53746-131-01 Bottles of 500: NDC 53746-131-05 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Avoid excessive heat 40°C (104°F). Dispense in a tight, light-resistant container as defined in the USP. Rx Only Distributed by: Amneal Pharmaceuticals LLC Bridgewater, NJ 08807 Rev. 05-2021-05


More pills like ROUND IP 131 400












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site